These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30643324)

  • 1. The Problem with the Current High Potency THC Marijuana from the Perspective of an Addiction Psychiatrist.
    Stuyt E
    Mo Med; 2018; 115(6):482-486. PubMed ID: 30643324
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands.
    Freeman TP; van der Pol P; Kuijpers W; Wisselink J; Das RK; Rigter S; van Laar M; Griffiths P; Swift W; Niesink R; Lynskey MT
    Psychol Med; 2018 Oct; 48(14):2346-2352. PubMed ID: 29382407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dab Alert.
    Maloney WJ
    N Y State Dent J; 2016 Mar; 82(2):8. PubMed ID: 27209710
    [No Abstract]   [Full Text] [Related]  

  • 4. Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system.
    Hoffman AF; Lupica CR
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23209160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice.
    Eckard ML; Kinsey SG
    Neuropharmacology; 2021 Jun; 190():108554. PubMed ID: 33845073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice.
    Trexler KR; Nass SR; Crowe MS; Gross JD; Jones MS; McKitrick AW; Siderovski DP; Kinsey SG
    Drug Alcohol Depend; 2018 Oct; 191():14-24. PubMed ID: 30071445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
    Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
    J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
    Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
    Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
    van Amsterdam J; Brunt T; van den Brink W
    J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness].
    Sagie S; Eliasi Y; Livneh I; Bart Y; Monovich E
    Harefuah; 2013 Dec; 152(12):737-41, 751. PubMed ID: 24483000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New trends in cannabis potency in USA and Europe during the last decade (2008-2017).
    Chandra S; Radwan MM; Majumdar CG; Church JC; Freeman TP; ElSohly MA
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):5-15. PubMed ID: 30671616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does change in cannabis use in established psychosis affect clinical outcome?
    Barrowclough C; Emsley R; Eisner E; Beardmore R; Wykes T
    Schizophr Bull; 2013 Mar; 39(2):339-48. PubMed ID: 22037770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
    Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cerebellum, THC, and Cannabis Addiction: Findings from Animal and Human Studies.
    Moreno-Rius J
    Cerebellum; 2019 Jun; 18(3):593-604. PubMed ID: 30610540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction.
    Chang X; Bian Y; He Q; Yao J; Zhu J; Wu J; Wang K; Duan T
    Cell Physiol Biochem; 2017; 42(2):537-550. PubMed ID: 28578322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabis experiment.
    Cressey D
    Nature; 2015 Aug; 524(7565):280-3. PubMed ID: 26295084
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users.
    Lorenzetti V; Solowij N; Yücel M
    Biol Psychiatry; 2016 Apr; 79(7):e17-31. PubMed ID: 26858212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does stronger cannabis cause more health problems?].
    Vindenes V; Bramness JG; Bretteville-Jensen AL; Mørland J; Bachs L
    Tidsskr Nor Laegeforen; 2016 Nov; 136(20):1736-1738. PubMed ID: 27830910
    [No Abstract]   [Full Text] [Related]  

  • 20. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
    JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.